Gland Pharma shares rally 6% as brokerages lift ratings, target prices; here’s why
Shares of Gland Pharma climbed as much as 6.4% on Wednesday to Rs 2,090.20 on BSE, as multiple brokerages upgraded the stock and raised target prices, citing a successful turnaround of its European unit Cenexi and a sharp expansion in operating margins in the June quarter. Jefferies upgraded the stock to ‘Hold’ from ‘Underperform’ and … Read more